New biomarker for neovascular age-related macular degeneration: Eotaxin-2

DNA and Cell Biology

Volumn 31, Issue 11, 2012, Pages 1618-1627

  Sharma, Neel Kamal ^a   Prabhakar, Sudesh ^a   Gupta, Amod ^a   Singh, Ramandeep ^a   Gupta, Pawan Kumar ^a   Gupta, Pramod Kumar ^a   Anand, Akshay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BIOLOGICAL MARKER; EOTAXIN 2;

ADULT; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION;

AGED; ALCOHOL DRINKING; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL MARKERS; CHEMOKINE CCL24; CHOROIDAL NEOVASCULARIZATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SMOKING; WET MACULAR DEGENERATION;

ANIMALIA;

EID: 84868010707     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1786     Document Type: Article

References (39)

1. Ambati, J.,Ambati, B.K., Yoo, S.H., Ianchulev, S., and Adamis,A.P. (2003a). Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48, 257-293.
2. Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B.C., Kuziel, W.A., Rollins, B.J., and Ambati, B.K. (2003b). An animal model of age-related macular degeneration in senescent Ccl-2 or Ccr-2-deficient mice. Nat Med 9, 1390-1397.
3. Azad, R., Chandra, P., and Gupta, R. (2007). The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration. Indian J Ophthalmol 55, 441-443.
4. Baas, D.C., Ho, L., Ennis, S., Merriam, J.E., Tanck, M.W.T., Uitterlinden, A.G., de Jong, P.T., Cree, A.J., Griffiths, H.L., Rivadeneira, F., Hofman, A., van Duijn, C., Smith, R.T., Barile, G.R., Gorgels, T.G., Vingerling, J.R., Klaver, C.C., Lotery, A.J., Allikmets, R., and Bergen, A.A. (2010). The complement component 5 gene and age-related macular degeneration. Ophthalmology 117, 500-511.
5. Chong, E.W., Kreis, A.J., Wong, T.Y., Simpson, J.A., and Guymer, R.H. (2008). Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol 145, 707-715.
6. Daugherty, B.L., Siciliano, S.J., DeMartino, J.A., Malkowitz, L., Sirotina, A., and Springer, M.S. (1996). Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 183, 2349-2354.
7. Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C.A., Langen, H., Thelen, M., and Baggiolini, M. (1997). Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185, 2171-2176.
8. Georgopoulos, M., Polak, K., Prager, F., Prunte, C., and Schmidt- Erfurth, U. (2009). Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol 93, 457-462.
9. Good, T.J., Kimura, A.E., Mandava, N., and Kahook, M.Y. (2011). Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol 95, 1111-1114.
10. Hogg, R.E., Woodside, J.V., Gilchrist, S.E., Graydon, R., Fletcher, A.E., et al. (2008). Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 115, 1046-1052.
11. Humbles, A.A., Lloyd, C.M., McMillan, S.J., Friend, D.S., Xanthou, G., et al. (2004). A critical role for eosinophils in allergic airways remodeling. Science 305, 1776-1779.
12. Jahnz-Rozyk, K., Targowski, T., Paluchowska, E., Owczarek, W., and Kucharczyk, A. (2005). Serum thymus and activationregulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60, 685-688.
13. Johnson, D., Hollands, H., Hollands, S., and Sharma, S. (2010). Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study. Can J Ophthalmol 45, 239-242.
14. Kabasawa, S., Mori, K., Horie-Inoue, K., Gehlbach, P.L., Inoue, S., Awata, T., Katayama, S., and Yoneya, S. (2011). Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology 18, 1082-1088.
15. Kagami, S., Kakinuma, T., Saeki, H., Tsunemi, Y., Fujita, H., Nakamura, K., Takekoshi, T., Kishimoto, M., Mitsui, H., Torii, H., Komine, M., Asahina, A., and Tamaki, K. (2003). Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 134, 309-313.
16. Kitaura, M., Nakajima, T., Imai, T., Harada, S., Combadiere, C., Tiffany, H.L., Murphy, P.M., and Yoshie, O. (1996). Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 271, 7725-7730.
17. Kitaura, M., Suzuki, N., Imai, T., Takagi, S., Suzuki, R., Nakajima, T., Hirai, K., Nomiyama, H., and Yoshie, O. (1999). Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 274, 27975-27980.
18. Li, Y., Huang, D., Xia, X., Wang, Z., Luo, L., and Wen, R. (2011). CCR3 and choroidal neovascularization. PLoS ONE 6, e17106.
19. Luster, A.D., and Rothenberg, M.E. (1997). Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 62, 620-633.
20. Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M.J., and Seddon, J.M. (2006). Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38, 1055-1059.
21. Manousou, P., Kolios, G., Valatas, V., Drygiannakis, I., Bourikas, L., Pyrovolaki, K., Koutroubakis, I., Papadaki, H.A., and Kouroumalis, E. (2010). Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies. Clin Exp Immunol 162, 337-347.
22. Mo, F.M.,Proia,A.D., Johnson,W.H., Cyr, D., and Lashkari,K. (2010). Interferon inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Retina 51, 4226-4236.
23. Petkovic, V., Moghini, C., Paoletti, S., Uguccioni, M., and Gerber, B. (2004). Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. J Biol Chem 22, 23357-23367.
24. Ponath, P.D., Qin, S., Ringler, D.J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J.A., Newman, W., Gutierrez-Ramos, J.C., and Mackay, C.R. (1996). Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97, 604-612.
25. Pope, S.M., Zimmermann, N., Stringer, K.F., Karow, M.L., and Rothenberg, M.E. (2005). The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 175, 5341-5350.
26. Rothenberg, M.E. (1999). Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 21, 291-295.
27. Salcedo, R., Young, H.A., Ponce, M.L., Ward, J.M., Kleinman, H.K., Murphy, W.J., and Oppenheim, J.J. (2001). Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR31 endothelial cells. J Immunol 166, 7571-7578.
28. Shah, A.R., and Del Priore, L.V. (2009). Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration. Ophthalmology 116, 1901-1907.
29. Shahabuddin, S., Ponath, P., and Schleimer, R.P. (2000). Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. J Immunol 164, 3847-3854.
30. Sharma, N.K., Prabhakar, S., and Anand, A. (2009). Age related macular degeneration - advances and trends. Ann Neurosci 2, 62-71.
31. Takeda, A., Baffi, J.Z., Kleinman, M.E., Cho, W.G., Nozaki, M., Yamada, K., Kaneko, H., Albuquerque, R.J.C., Dridi, S., Saito, K., Raisler, B.J., Budd, S.J., Geisen, P., Munitz, A., Ambati, B.K., Green, M.G., Ishibashi, T., Wright, J.D., Humbles, A.A., Gerard, C.J., Ogura, Y., Pan, Y., Smith, J.R., Grisanti, S., Hartnett, M.E., Rothenberg, M.E., and Ambati, J. (2009). CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460, 225-230.
32. Teixeira, M.M., Wells, T.N., Lukacs, N.W., Proudfoot, A.E., Kunkel, S.L., Williams, T.J., and Hellewell, P.G. (1997). Chemokine- induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 100, 1657-1666.
33. Tin, L.L., Beevers, D.G., and Lip, G.Y.H. (2002). Systolic vs. diastolic blood pressure and the burden of hypertension. J Hum Hypertens 16, 147-150.
34. Vinish, M., Prabhakar, S., Khullar, M., Verma, I., and Anand, A. (2010). Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India. J Neurol Neurosurg Psychiatry 81, 166-170.
35. Wang, H., Wittchen, E.S., Jiang, Y., Ambati, B., and Grossniklaus, H.E. (2011). Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest Ophthalmol Vis Sci 52, 8271-8277.
36. White, J.R., Imburgia, C., Dul, E., Appelbaum, E., and O'Donnell, K. (1997). Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 62, 667-675.
37. Wickremasinghe, S.S., Michalova, K., Gilhotra, J., Guymer, R.H., Harper, C.A., Wong, T.Y., and Qureshi, S. (2008). Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology 115, 1911-1915.
38. Yawalkar, N., Uguccioni, M., Scharer, J., Braunwalder, J., and Karlen, S. (1999). Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113, 43-48.
39. Zimmermann, N., Hogan, S.P., Mishra, A., Brandt, E.B., Bodette, T.R., et al. (2000). Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165, 5839-5846.